Weekly Gemcitabine and Docetaxel in Refractory Soft Tissue Sarcoma: A Retrospective Analysis

PURPOSE: The combination of gemcitabine and docetaxel (GD) is used to effectively treat patients with soft tissue sarcoma (STS). It is widely considered that the conventional doses used are too high for long term use and many patients must discontinue GD treatment due to its toxicity. Therefore, to...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Lee, Ha-young, Shin, Sang Joon, Kim, Hyo Song, Hong, Soo Jung, Han, Jung Woo, Lim, Seung Taek, Roh, Jae Kyung, Rha, Sun Young
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Cancer Association 2012
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3322200/
https://ncbi.nlm.nih.gov/pubmed/22500160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2012.44.1.43
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi